Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Non Operating Income (2021 - 2026)

Updated

Valion Bio (VBIO) reported Non Operating Income of -$633,000 for Q2 2026, compared with $3,000 a year earlier.

Analysis

Valion Bio (VBIO) Non Operating Income (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Valion Bio's Non Operating Income came in at -$732,000; for FY2025, it was -$95,000.

  • By year, Non Operating Income came in at $6,000 in FY2024 (+500.0%), $1,000 in FY2023 (-50.0%), $2,000 in FY2022 and -$2.86 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Non Operating Income since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 387.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Valion Bio 129,792.00 -19.31 Mn - -633,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -633,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 -113,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 6,000.00
Jun 30, 2024 -60,000.00
Dec 31, 2022 2,000.00
Mar 31, 2022 1,000.00
Dec 31, 2021 -1.43 Mn
Sep 30, 2021 -1.09 Mn
Jun 30, 2021 -39,000.00
Mar 31, 2021 -299,000.00
API Access

Valion Bio Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=VBIO&period=max&api_key=YOUR_API_KEY